3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Interventions
venetoclax
18
Rituximab
14
ibrutinib
13
obinutuzumab
10
acalabrutinib
10
Specimen Handling
10
Cyclophosphamide
9
Biopsy
9
zanubrutinib
8
pirtobrutinib
6
Magnetic Resonance Spectroscopy
5
Lenalidomide
5
idelalisib
4
fludarabine phosphate
4
Cyclosporine
4
CT-P10
4
Bendamustine Hydrochloride
4
ARQ531
4
Whole-Body Irradiation
3
Vincristine
3
Sirolimus
3
Prednisone
3
Mycophenolic Acid
3
Doxorubicin
3
tafasitamab
2
pembrolizumab
2
fludarabine
2
Immunoglobulins
2
Disulfides
2
Cyclosporins
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia, Lymphocytic, Chronic, B-Cell
×
Hizentra
×
30 days
×
Clear all
NCT07582432
2026-05-12
SIGMA
Grifols Biologicals, LLC
Phase 3
Recruiting
49 enrolled